ADOCIA Revenue and Competitors
Estimated Revenue & Valuation
- ADOCIA's estimated annual revenue is currently $16.9M per year.
- ADOCIA's estimated revenue per employee is $155,000
Employee Data
- ADOCIA has 109 Employees.
- ADOCIA grew their employee count by -3% last year.
ADOCIA's People
| Name | Title | Email/Phone |
|---|
ADOCIA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is ADOCIA?
"Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en
keywords:N/AN/A
Total Funding
109
Number of Employees
$16.9M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ADOCIA News
Adocia (Euronext Paris: FR0011184241 ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and...
Adocia: Number of Shares and Voting Rights of ADOCIA as of March 31st, 2022. April 15, 2022 12:00 PM Eastern Daylight Time. LYON, France--(BUSINESS...
LYON, France, March 28, 2022 (GLOBE NEWSWIRE) -- Adocia (Euronext Paris : FR0011184241 ADOC), a clinical-stage biopharmaceutical company...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.7M | 109 | 4% | N/A |
#2 | $30M | 111 | -11% | N/A |
#3 | $36.7M | 112 | 12% | N/A |
#4 | $16.2M | 112 | 35% | N/A |
#5 | $16.2M | 112 | 22% | N/A |
